WGA-coated yttrium oxide beads enable an imaging-based adenosine 2a receptor binding scintillation proximity assay suitable for high throughput screening.

Adenosine receptors belong to the superfamily of G protein-coupled receptors and are involved in a variety of physiologic functions. Traditionally, binding assays to detect adenosine 2a (A2a) antagonists and agonists have used filtration methods that are cumbersome to run and not amenable to HTS. We developed scintillation proximity assays (SPA trade mark ) utilizing HEK293 RBHA2AM cell membranes, either wheat germ agglutinin (WGA)-coated yttrium silicate (YSi) or red-shifted yttrium oxide (YO) beads and the A2a-selective radioligand [(3)H]SCH 58261. Both beads gave windows (total binding/nonspecific binding) of >5 and K(d) values of 2-3 nM for the radioligand, in agreement with results obtained by filtration. In contrast, WGA-polyvinyltoluene as well as other bead types had windows of <3 and significant radioligand binding to the uncoated beads. A 384-well WGA-YO bead SPA was optimized utilizing a LEADseeker imaging system and an automated trituration process for dispensing the dense yttrium-based beads. Signals were stable after 4 h, and Z' values were 0.7-0.8. The LEADseeker imaging assay tolerated 2% dimethyl sulfoxide and generated IC(50) values of 3-5 nM for the A2a antagonist CGS 15943, comparable to that obtained by the filtration method. A number of adenosine and xanthine analogues were identified as hits in the Library of Pharmacologically Active Compounds (LOPAC). This imaging-based A2a SPA enables HTS and is a major improvement over the filtration method.

[1]  S. Schiffmann,et al.  Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor , 1997, Nature.

[2]  A. Gubitz,et al.  Tissue distribution of adenosine receptor mRNAs in the rat , 1996, British journal of pharmacology.

[3]  B. Fredholm,et al.  Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]‐SCH 58261 , 1997, British journal of pharmacology.

[4]  C. Strader,et al.  SCH 57790: a novel M2 receptor selective antagonist. , 1999, Life sciences.

[5]  A. Goetz,et al.  Development of scintillation-proximity assays for alpha adrenoceptors. , 1999, Journal of pharmacological and toxicological methods.

[6]  Y. Chern,et al.  Molecular cloning of a novel adenosine receptor gene from rat brain. , 1992, Biochemical and biophysical research communications.

[7]  E. M. Adler,et al.  Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum. , 1992, Brain research. Molecular brain research.

[8]  K. Klotz Adenosine receptors and their ligands , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[9]  Robert W. Bryant,et al.  Evaluation of Fluorescent Compound Interference in 4 Fluorescence Polarization Assays: 2 Kinases, 1 Protease, and 1 Phosphatase , 2003, Journal of biomolecular screening.

[10]  D. Hanniford,et al.  Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes. , 2005, Assay and drug development technologies.

[11]  P. Jenner,et al.  Adenosine A2A Antagonist: A novel antiparkinsonian agent that does not provoke dyskinesia in Parkinsonian monkeys , 1998, Annals of neurology.

[12]  Peter Ramm,et al.  Image-based screening: a technology in transition. , 2005, Current opinion in biotechnology.

[13]  T. Chung,et al.  A scintillation proximity assay for rna detection. , 2001, Analytical biochemistry.

[14]  Ralf Heilker,et al.  Automated High Throughput Screening for Serine Kinase Inhibitors Using a LEADSeeker™ Scintillation Proximity Assay in the 1536-Well Format , 2002, Journal of biomolecular screening.

[15]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.